- Home
- Companies
- north america
- diabetes macular edema
Refine by
Diabetes Macular Edema Suppliers In North America
5 companies found
Manufacturerbased inBillerica, MASSACHUSETTS (USA)
Aesthetic, Vision, and Surgical lasers and related technology, was established in 1997 to bring intuitive, robust, versatile devices which are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic ...
R:GEN is the only retinal laser proven to deliver safe, efficacious and precise targeting of Retinal Pigment Epithelium (RPE) cells. R:GEN’s proprietary Real-Time Feedback, Dual Dosimetry, and Auto Ramp-up technologies ensure precise targeting ...
Manufacturerbased inMarlborough, MASSACHUSETTS (USA)
IPG Photonics is the inventor and world’s leading producer of high-power fiber lasers, which enable greater precision, higher speed processing, more flexible production methods and enhanced productivity. IPG has a rich history of innovation, ...
Historically, ophthalmology was the first medical field where lasers have found an application. Over more than five decades, use of lasers in ophthalmology has successfully shown effective and safe results in treating various eye conditions. Whether ...
Manufacturerbased inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic ...
Manufacturerbased inMalvern, PENNSYLVANIA (USA)
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. Our breakthrough modifier gene therapy platform ...
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and ...
Manufacturerbased inCoralville, IOWA (USA)
In April 2018, Digital Diagnostics(formerly known as IDx) became the first company to ever receive FDA clearance for an AI diagnostic platform that makes a diagnosis without physician input at the point-of-care. This achievement did not happen ...
IDx-DR is an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy (including macular ...